Viewing nowCrestor 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

MFDS item code 200410326 · Approved 2004.08.31 · Insurance code 650700530
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct when dietary measures and exercise are insufficient for patients with primary hypercholesterolemia and mixed dyslipidemia. It also assists in patients with homozygous familial hypercholesterolemia as an adjunct to diet or other lipid-lowering therapies. It effectively lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis. In certain cases among pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia, it is used as an adjunct to diet to lower cholesterol and apo-B protein levels. It is also used as an adjunct to diet in patients with primary dysbetalipoproteinemia. Furthermore, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in specific high-risk patients with cardiovascular disease risk factors. It is effectively used for a variety of hypercholesterolemia and cardiovascular disease risk reduction.
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this product and continue it throughout treatment. This product may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this product to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this product to patients with active liver disease. 6. Race: Because systemic exposure to this product is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of a 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of a 40-milligram dose of this product is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 ~ 17 years): The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Children under 10 years: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, patients with allergies to this medication, severely impaired liver function, muscle disorders, specific renal dysfunction, pregnant or breastfeeding women, and fertile women not using adequate contraception should not take this medication. Additionally, patients at high risk for muscle disorders, such as those with moderate to severe renal impairment, hypothyroidism, a family history of muscle disorders, alcoholics, Asians, and patients taking fibrate drugs are prohibited from receiving high doses of this medication. This medication contains lactose; therefore, patients with lactose intolerance or related genetic diseases should not take it. Caution is needed for patients consuming excessive alcohol or with a history of liver disease while taking this medication, and repeating liver function tests before and during treatment is recommended. Moreover, if symptoms such as muscle pain, weakness, or cramps occur, they should immediately inform their healthcare provider. Patients at high risk for muscle-related side effects must carefully weigh the risks and benefits of treatment, and muscle enzyme levels should be checked before starting treatment; if abnormalities are found, administration should not begin. Severe muscle weakness or ocular myasthenia may occur; hence, discontinuation of the medication should be considered if symptoms appear. This medication, when used in combination with certain other drugs, may increase serum concentration and raise the risk of muscle side effects, so patients should consult their healthcare provider about concomitant medications. It should not be used during pregnancy or while breastfeeding, and women of childbearing potential should use suitable contraceptive methods. In case of overdose, there is no specific antidote, and treatment should be symptomatic; liver function and muscle enzyme levels should be regularly monitored. Dizziness may occur while driving or operating machinery, so caution is advised. Rarely, serious side effects such as severe skin reactions, liver damage, neurological abnormalities, and muscle rupture may occur, so if unusual symptoms arise, patients should immediately inform their healthcare provider. Lastly, the drug's plasma concentration may be higher in Asians; thus, dosage adjustments may be necessary.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced para-urticarial rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, abnormal sensations, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and humidity; therefore, it should be stored in a tightly sealed container. It is important to maintain storage temperatures between 1°C and 30°C. Proper storage will help preserve the medication’s effectiveness.
Pink round film-coated tablets
30 tablets/bottle, 30 tablets (15 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Kyeongbo Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.